Literature DB >> 20626618

Elevated tissue factor expression contributes to exacerbated diabetic nephropathy in mice lacking eNOS fed a high fat diet.

F Li1, C-H Wang, J-G Wang, T Thai, G Boysen, L Xu, A L Turner, A S Wolberg, N Mackman, N Maeda, N Takahashi.   

Abstract

BACKGROUND: Human eNOS (NOS3) polymorphisms that lower its expression are associated with advanced diabetic nephropathy (DN), and the lack of eNOS accelerates DN in diabetic mice. Diabetes is associated with fibrin deposition. Lack of nitric oxide and fatty acids stimulates the NF-kB pathway, which increases tissue factor (TF).
OBJECTIVES: To test the hypothesis that TF contributes to the severity of DN in the diabetic eNOS(-/-) mice fed a high-fat diet (HF).
METHODS: We made eNOS(-/-) and wild-type mice diabetic with streptozotocin. Half of them were placed on HF.
RESULTS: Blood glucose levels were not affected by either the diet or eNOS genotype. Lack of eNOS in the diabetic mice increased urinary albumin excretion, glomerulosclerosis, interstitial fibrosis, and glomerular basement membrane thickness. HF by itself did not affect DN in the wild-type mice, but significantly enhanced DN in eNOS(-/-) mice. More than half of diabetic eNOS(-/-) mice on HF died prematurely with signs of thrombotic complications. Diabetic kidneys contained fibrin and TF, and their levels were increased by the lack of eNOS and by HF in an additive fashion. The HF diet increased the kidney expression of inflammatory genes. The increase in TF preceded DN, and administration of an anti-mouse TF antibody to diabetic mice reduced the expression of inflammatory genes.
CONCLUSION: Together, these data indicate a causal link between TF and the exacerbation of DN in eNOS(-/-) mice. The condition is significantly worsened by enhanced inflammatory responses to an HF diet via TF.
© 2010 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20626618      PMCID: PMC5744483          DOI: 10.1111/j.1538-7836.2010.03976.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  45 in total

1.  alpha-Lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/low-cholesterol diet.

Authors:  Xianwen Yi; Nobuyo Maeda
Journal:  Diabetes       Date:  2006-08       Impact factor: 9.461

2.  Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate.

Authors:  N Takahashi; G Boysen; F Li; Y Li; J A Swenberg
Journal:  Kidney Int       Date:  2006-12-06       Impact factor: 10.612

3.  Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase.

Authors:  H Duplain; R Burcelin; C Sartori; S Cook; M Egli; M Lepori; P Vollenweider; T Pedrazzini; P Nicod; B Thorens; U Scherrer
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

4.  Dietary lipid lowering reduces tissue factor expression in rabbit atheroma.

Authors:  M Aikawa; S J Voglic; S Sugiyama; E Rabkin; M B Taubman; J T Fallon; P Libby
Journal:  Circulation       Date:  1999-09-14       Impact factor: 29.690

5.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

Authors:  E G Shesely; N Maeda; H S Kim; K M Desai; J H Krege; V E Laubach; P A Sherman; W C Sessa; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

6.  Endothelial dysfunction precedes atherosclerotic lesions and platelet activation in high fat diet-induced prothrombotic state.

Authors:  Rumiko Aoki; Hideo Ikarugi; Aki Naemura; Yoshinobu Ijiri; Tsutomu Yamashita; Junichiro Yamamoto
Journal:  Thromb Res       Date:  2006       Impact factor: 3.944

7.  Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

Authors:  M P Wautier; O Chappey; S Corda; D M Stern; A M Schmidt; J L Wautier
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-05       Impact factor: 4.310

Review 8.  Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis.

Authors:  Rafal Pawlinski; Nigel Mackman
Journal:  Crit Care Med       Date:  2004-05       Impact factor: 7.598

9.  Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.

Authors:  Yukiko Kanetsuna; Keiko Takahashi; Michio Nagata; Maureen A Gannon; Matthew D Breyer; Raymond C Harris; Takamune Takahashi
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 10.  Mouse models of diabetic nephropathy.

Authors:  Frank C Brosius; Charles E Alpers; Erwin P Bottinger; Matthew D Breyer; Thomas M Coffman; Susan B Gurley; Raymond C Harris; Masao Kakoki; Matthias Kretzler; Edward H Leiter; Moshe Levi; Richard A McIndoe; Kumar Sharma; Oliver Smithies; Katalin Susztak; Nobuyuki Takahashi; Takamune Takahashi
Journal:  J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 10.121

View more
  10 in total

1.  A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy.

Authors:  Chih-Hong Wang; Feng Li; Sylvia Hiller; Hyung-Suk Kim; Nobuyo Maeda; Oliver Smithies; Nobuyuki Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-18       Impact factor: 11.205

2.  Tonicity-Responsive Enhancer-Binding Protein Mediates Hyperglycemia-Induced Inflammation and Vascular and Renal Injury.

Authors:  Soo Youn Choi; Sun Woo Lim; Shabnam Salimi; Eun Jin Yoo; Whaseon Lee-Kwon; Hwan Hee Lee; Jun Ho Lee; Braxton D Mitchell; Satoru Sanada; Afshin Parsa; Hyug Moo Kwon
Journal:  J Am Soc Nephrol       Date:  2017-11-20       Impact factor: 10.121

3.  Causative Effects of Genetically Determined High Maternal/Fetal Endothelin-1 on Preeclampsia-Like Conditions in Mice.

Authors:  Feng Li; Masao Kakoki; Marcela Smid; Kim Boggess; Jennifer Wilder; Sylvia Hiller; Carol Bounajim; Scott E Parnell; Kathleen K Sulik; Oliver Smithies; Nobuyo Maeda-Smithies
Journal:  Hypertension       Date:  2018-04-02       Impact factor: 10.190

4.  Myeloid cell-derived coagulation tissue factor is associated with renal tubular damage in mice fed an adenine diet.

Authors:  Shu Yamakage; Yuji Oe; Emiko Sato; Koji Okamoto; Akiyo Sekimoto; Satoshi Kumakura; Hiroshi Sato; Mai Yoshida; Tasuku Nagasawa; Mariko Miyazaki; Sadayoshi Ito; Nigel Mackman; Nobuyuki Takahashi
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

5.  Tissue factor, blood coagulation, and beyond: an overview.

Authors:  Arthur J Chu
Journal:  Int J Inflam       Date:  2011-09-20

Review 6.  Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice.

Authors:  Takamune Takahashi; Raymond C Harris
Journal:  J Diabetes Res       Date:  2014-10-13       Impact factor: 4.011

7.  Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury.

Authors:  Yuji Oe; Tomofumi Fushima; Emiko Sato; Akiyo Sekimoto; Kiyomi Kisu; Hiroshi Sato; Junichi Sugawara; Sadayoshi Ito; Nobuyuki Takahashi
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

Review 8.  Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers.

Authors:  Li Lai; Yohannes T Ghebremariam
Journal:  J Diabetes Res       Date:  2015-12-06       Impact factor: 4.011

9.  Oral high dose vitamin B12 decreases renal superoxide and post-ischemia/reperfusion injury in mice.

Authors:  Feng Li; Edward M Bahnson; Jennifer Wilder; Robin Siletzky; John Hagaman; Volker Nickekeit; Sylvia Hiller; Azraa Ayesha; Lanfei Feng; Jerrold S Levine; Nobuyuki Takahashi; Nobuyo Maeda-Smithies
Journal:  Redox Biol       Date:  2020-03-10       Impact factor: 11.799

10.  Beneficial effects of nicotinamide on hypertensive mice with impaired endothelial nitric oxide function.

Authors:  Phillip K Huynh; Jen Wilder; Sylvia Hiller; John Hagaman; Nobuyuki Takahashi; Nobuyo Maeda-Smithies; Feng Li
Journal:  J Exp Nephrol       Date:  2020
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.